Почетна › Мозгове туморске промене › Тексас
Kliničke studije za Мозгове туморске промене u državi Тексас
42 studija za Мозгове туморске промене traži učesnike na lokacijama u državi Тексас.
Gradovi u državi Тексас
Zvanični tekst studije (na engleskom)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- UT MD Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07326566S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- UT Southwestern Clinical Center at Richardson/Plano, Richardson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03418961A Phase I Clinical Study of YN003 in the Treatment of Glioma
- The University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст од 18 до 70 · Оба пола · Ажурирано 10. 11. 2026. · NCT07929909Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
- M D Anderson Cancer Center, Houston
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT02754544A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
- M D Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT05342454Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
- MD Anderson Cancer Center, Houston
Тражи се учесник
Узраст од 15 до 39 · Оба пола · Ажурирано 6. 11. 2026. · NCT06799481A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07492680Mapping of Human Cognition
- The University of Texas Health Science Center at Houston, Houston
Тражи се учесник
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT05989893A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- UT MD Anderson Cancer Center, Houston
- UT Health San Antonio Mays Cancer Center, San Antonio
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07428616Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06810544Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT05460507Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- MD Anderson Cancer Center, Houston
- START San Antonio, San Antonio
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT05786924Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT05386108Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
- M D Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05064280EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
- The University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT06649058GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
- Baylor St. Luke's Medical Center, Houston
Тражи се учесникФаза 1
Узраст од 21 до 70 · Оба пола · Ажурирано 30. 9. 2026. · NCT06815432Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Baylor, Scott and White Research Institute, Dallas
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT06047379Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
- Mays Cancer Center, UT Health San Antonio, San Antonio
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07470606Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
- The University of Texas M. D. Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT07053033A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
- M D Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT05048212OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
- MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT07655583Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
Тражи се учесникФаза 2
59 Months · Оба пола · Ажурирано 15. 9. 2026. · NCT05535166Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
- M D Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT04988009A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
- MD Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT07467109A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NEXT Oncology - Austin, Austin
- Mary Crowley Cancer Research, Dallas
- MD Anderson Cancer Center - University of Texas, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06253871Targeted Pediatric High-Grade Glioma Therapy
- Texas Children's Hospital, Houston
Тражи се учесникОпсервациона студија
12 Months – 39 Years · Оба пола · Ажурирано 8. 9. 2026. · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1
36 Months – 22 Years · Оба пола · Ажурирано 4. 9. 2026. · NCT03911388Study of Olutasidenib and Temozolomide in HGG
- Texas Children's Hospital, Houston
Тражи се учесникФаза 2
Узраст од 12 до 39 · Оба пола · Ажурирано 1. 9. 2026. · NCT06161974A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
- MD Anderson Cancer Center, Houston
- Community Clinical Trials, Kingwood
- Tranquil Clinical Research, Webster
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 21. 8. 2026. · NCT06764940Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)
- Ut Southwestern Medical Center, Dallas
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT07139990A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
- Mary Crowley Cancer Research, Dallas
- The University of Texas M.D. Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT06136884Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
- Houston Methodist Neal Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 10. 8. 2026. · NCT07383649Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
- Excel Diagnostics & Nuclear Oncology Center, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 7. 8. 2026. · NCT07733674C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
- Texas Children's Hospital, Houston
Тражи се учесникФаза 1
12 Months – 25 Years · Оба пола · Ажурирано 3. 8. 2026. · NCT04099797Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- UT Southwestern Simmons Cancer Center, Dallas
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
- и још 2
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 22. 7. 2026. · NCT04427384A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
- M D Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 16. 7. 2026. · NCT05673928Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- M D Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст 19 и старији · Оба пола · Ажурирано 16. 7. 2026. · NCT03830151Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Texas Children's Hospital, Houston
Тражи се учесникФаза 2
12 Months – 39 Years · Оба пола · Ажурирано 29. 5. 2026. · NCT05843253The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Md Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 5. 3. 2026. · NCT04075305Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
- M D Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 5. 2. 2026. · NCT05700721Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.